The blood-brain barrier -; a network of blood vessels and tissues that nurtures and protects the brain from harmful substances circulating in the blood -; is disrupted in Alzheimer's disease.
Mayo ClinicJun 26 2024 The blood-brain barrier -; a network of blood vessels and tissues that nurtures and protects the brain from harmful substances circulating in the blood -; is disrupted in Alzheimer's disease. Now, researchers at Mayo Clinic and collaborators have uncovered unique molecular signatures of blood-brain barrier dysfunction that could point to new ways to diagnose and treat the disease. Their findings are published in Nature Communications.
Nilüfer Ertekin-Taner, M.D., Ph.D., senior author, chair of the Department of Neuroscience at Mayo Clinic and leader of the Genetics of Alzheimer's Disease and Endophenotypes Laboratory at Mayo Clinic, Florida They focused on brain vascular cells, which make up a small portion of cell types in the brain, to examine molecular changes associated with Alzheimer's disease. In particular, they looked at two cell types that play an important role in maintaining the blood-brain barrier: pericytes, the gatekeepers of the brain that maintain the integrity of blood vessels, and their support cells known as astrocytes, to determine if and how they interact.
Related StoriesThe team used stem cells from blood and skin samples of the Alzheimer's disease patient donors and those in the control group. They treated the cells with VEGFA to see how it affected SMAD3 levels and overall vascular health. The VEGFA treatment caused a decline in SMAD3 levels in brain pericytes, indicating interaction between these molecules.
Vascular Blood Blood Vessels Cell Genetics Laboratory Neuroscience Pericytes Ph Research
United Kingdom Latest News, United Kingdom Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Researchers identify vascular changes in the brain linked to Alzheimer's diseaseThe blood-brain barrier—a network of blood vessels and tissues that nurtures and protects the brain from harmful substances circulating in the blood—is disrupted in Alzheimer's disease.
Read more »
Researchers unravel complexities of Alzheimer's disease in protein fragments and plaque diversityAlzheimer's disease (AD) remains one of the most challenging and prevalent neurodegenerative disorders, affecting millions worldwide. In two recent studies, researchers led by Prof. Lucía Chávez Gutiérrez (VIB-KU Leuven), Prof. William Mobley (UCSD, U.S.), and Prof.
Read more »
Researchers examine evidence for a novel neuronal mechanism driving Alzheimer's diseaseAn international team of clinicians and neuroscientists have published a new perspective on the process of neurodegeneration. Their findings review evidence for a mechanism upstream of amyloid including the key neurochemical driving this process.
Read more »
Researchers identify novel way to potentially slow down or halt Alzheimer’s progressionResearchers at the Icahn School of Medicine at Mount Sinai have made a significant breakthrough in Alzheimer's disease research by identifying a novel way to potentially slow down or even halt disease progression.
Read more »
Researchers create brain organoid to investigate effects of COVID-19 in people with Down syndromeA first-of-its kind brain organoid grown at The University of Queensland has helped researchers identify therapies that reduce the impact of COVID-19 on people with Down syndrome.
Read more »
Researchers say AI blood test provides a reliable way to identify lung cancerUsing artificial intelligence technology to identify patterns of DNA fragments associated with lung cancer, researchers from the Johns Hopkins Kimmel Cancer Center and other institutions have developed and validated a liquid biopsy that may help identify lung cancer earlier.
Read more »